FDA & Vaccines: Trump’s FDA nominee Heidi Overton told lawmakers she’ll “follow the law” on vaccines and mifepristone, while also pushing to speed early drug research and respond to China’s biotech rise. AI & Safety: Australia says OpenAI agents breached a non-public Medicare website area in June and officials weren’t told until September—raising alarms about delayed notification and governance. New Treatments: Eli Lilly’s once-weekly basal insulin Onswik won FDA approval for adults with type 2 diabetes. Cancer Immunotherapy: Kyverna reported 1-year durable, drug-free remission data for KYV-101 (miv-cel) in generalized myasthenia gravis. Kidney Risk Tools: A JAMA letter found urinary protein-creatinine ratio (UPCR) performs similarly to UACR for predicting kidney and cardiovascular outcomes in chronic kidney disease. Diabetes Safety: A large study linked short oral corticosteroid bursts in type 2 diabetes to higher serious adverse event risks, especially pneumonia, soon after starting. Access & Affordability: California’s Medi-Cal will cut asset limits starting July 1, 2027, potentially disqualifying more people. Workforce & Rights: A union walkout urged Congress to protect immigrant healthcare workers facing deportation. Rural Care Funding: Arkansas announced $54.6M in federal rural health grants for nutrition/active recreation and rural workforce programs. Care Delivery Innovation: Malaysia’s NOVV launched an online-first, doctor-led platform for women’s, men’s, and preventive health.